SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Protein Design Labs (PDLI): Stock strong -- Ignore unavailable to you. Want to Upgrade?

To: mopgcw who wrote (194)3/15/2002 11:41:58 AM
From: lazarre  Respond to of 407
 
Anyone,

I just began following this stock a few days ago and I'm looking for an entry point. If the following guys are on target:

"If Zenapax fails in the study, Protein Design Labs shares will fall and create an attractive entry point for investors, said Morgan Stanley analysts Caroline Copithorne and Ian Somaiya in a research note Monday. They had initiated coverage with a neutral"

anyone have an idea---technically or fundamentally--where support might be if the above takes place?

tia

lazarre



To: mopgcw who wrote (194)3/20/2002 6:26:34 PM
From: nigel bates  Read Replies (2) | Respond to of 407
 
Others, though, have said investors should wait for Zenapax study results before buying shares.
If Zenapax fails in the study, Protein Design Labs shares will fall and create an attractive entry point for investors, said Morgan Stanley analysts Caroline Copithorne and Ian Somaiya in a research note Monday.

Got to give them some credit for the call. Wonder if they will be buying tomorrow ?

nig


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News